Since the cGAS-STING signaling is involved in the innate and adaptive immunity in human body, search for and identification of specific small molecules to suppress or reduce cGAS-STING signaling activity could be used as a novel approach in control of various human diseases, like AIDs, NASH, or even cancers. Here, STING1 is linked to metabolic dysfunction-associated steatohepatitis.